The global T-Cell therapy market size in 2023 is 3055.0 million US dollars, and it is expected to be 9446.6 million US dollars by 2030, with a compound annual growth rate of 17.5% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the T-Cell therapy market include Merck KGaA, Johnson & Johnson, AbbVie, Inc., Gilead Sciences, Inc., and Amgen, Inc.. The share of the top 3 players in the T-Cell therapy market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of T-Cell therapy market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Lymphoma accounted for XX% of T-Cell therapy market in 2023. Acute Lymphocytic Leukemia share of XX%.
Hospitals accounted for XX% of the T-Cell therapy market in 2023. Cancer Treatment Centers accounts for XX%.

This T-Cell therapy market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

T-Cell therapy market country level analysis
The countries covered in the T-Cell therapy market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and T-Cell therapy Market Share Analysis
T-Cell therapy market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the T-Cell therapy market.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the T-Cell therapy industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of T-Cell therapy market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global T-Cell therapy market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa T-Cell therapy market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the T-Cell therapy business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa

Player list
Merck KGaA
Johnson & Johnson
AbbVie, Inc.
Gilead Sciences, Inc.
Amgen, Inc.
Novartis AG
Sorrento Therapeutics, Inc.
Bristol Myers Squibb Company
Immunocore Holdings plc
Pfizer, Inc.

Types list
Lymphoma
Acute Lymphocytic Leukemia
Others

Application list
Hospitals
Cancer Treatment Centers

Table of Content

1 Market Overview
1.1 T-Cell therapy Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global T-Cell therapy Market Size & Forecast
1.4.1 Global T-Cell therapy Revenue (2019 VS 2023 VS 2030)
1.4.2 Global T-Cell therapy Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 T-Cell therapy Market Drivers
1.5.2 T-Cell therapy Market Restraints
1.5.3 T-Cell therapy Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Merck KGaA
2.1.1 Business Overview
2.1.2 Merck KGaA SWOT Analysis
2.1.3 Merck KGaA T-Cell therapy Products and Service Offered
2.1.4 Merck KGaA T-Cell therapy Revenue and Gross Margin
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Johnson & Johnson SWOT Analysis
2.2.3 Johnson & Johnson T-Cell therapy Products and Service Offered
2.2.4 Johnson & Johnson T-Cell therapy Revenue and Gross Margin
2.3 AbbVie, Inc.
2.3.1 Business Overview
2.3.2 AbbVie, Inc. SWOT Analysis
2.3.3 AbbVie, Inc. T-Cell therapy Products and Service Offered
2.3.4 AbbVie, Inc. T-Cell therapy Revenue and Gross Margin
2.4 Gilead Sciences, Inc.
2.4.1 Business Overview
2.4.2 Gilead Sciences, Inc. SWOT Analysis
2.4.3 Gilead Sciences, Inc. T-Cell therapy Products and Service Offered
2.4.4 Gilead Sciences, Inc. T-Cell therapy Revenue and Gross Margin
2.5 Amgen, Inc.
2.5.1 Business Overview
2.5.2 Amgen, Inc. SWOT Analysis
2.5.3 Amgen, Inc. T-Cell therapy Products and Service Offered
2.5.4 Amgen, Inc. T-Cell therapy Revenue and Gross Margin
2.6 Novartis AG
2.6.1 Business Overview
2.6.2 Novartis AG SWOT Analysis
2.6.3 Novartis AG T-Cell therapy Products and Service Offered
2.6.4 Novartis AG T-Cell therapy Revenue and Gross Margin
2.7 Sorrento Therapeutics, Inc.
2.7.1 Business Overview
2.7.2 Sorrento Therapeutics, Inc. SWOT Analysis
2.7.3 Sorrento Therapeutics, Inc. T-Cell therapy Products and Service Offered
2.7.4 Sorrento Therapeutics, Inc. T-Cell therapy Revenue and Gross Margin
2.8 Bristol Myers Squibb Company
2.8.1 Business Overview
2.8.2 Bristol Myers Squibb Company SWOT Analysis
2.8.3 Bristol Myers Squibb Company T-Cell therapy Products and Service Offered
2.8.4 Bristol Myers Squibb Company T-Cell therapy Revenue and Gross Margin
2.9 Immunocore Holdings plc
2.9.1 Business Overview
2.9.2 Immunocore Holdings plc SWOT Analysis
2.9.3 Immunocore Holdings plc T-Cell therapy Products and Service Offered
2.9.4 Immunocore Holdings plc T-Cell therapy Revenue and Gross Margin
2.10 Pfizer, Inc.
2.10.1 Business Overview
2.10.2 Pfizer, Inc. SWOT Analysis
2.10.3 Pfizer, Inc. T-Cell therapy Products and Service Offered
2.10.4 Pfizer, Inc. T-Cell therapy Revenue and Gross Margin
3 Global T-Cell therapy Market Competition, by Manufacturer
3.1 Global T-Cell therapy Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 T-Cell therapy Players Market Share in 2023
3.2.2 Top 6 T-Cell therapy Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 T-Cell therapy Players Head Office, Business Provided
3.4 T-Cell therapy Mergers & Acquisitions
3.5 T-Cell therapy New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global T-Cell therapy Revenue in Value by Type (2019-2030)
4.2 Global T-Cell therapy Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global T-Cell therapy Revenue by Application (2019-2030)
5.2 Global T-Cell therapy Revenue Share by Application (2019-2030)
6 Global T-Cell therapy Market Analysis by Regions
6.1 Global T-Cell therapy Revenue and Market Share by Regions
6.1.1 Global T-Cell therapy Revenue by Regions (2019-2030)
6.1.2 Global T-Cell therapy Revenue Market Share by Regions (2019-2030)
6.2 North America T-Cell therapy Revenue and Growth (2019-2030)
6.3 Europe T-Cell therapy Revenue and Growth (2019-2030)
6.4 Asia Pacific T-Cell therapy Revenue and Growth (2019-2030)
6.5 South America T-Cell therapy Revenue and Growth (2019-2030)
6.6 Middle East and Africa T-Cell therapy Revenue and Growth (2019-2030)
7 North America T-Cell therapy by Country, by Type, and by Application
7.1 North America T-Cell therapy Revenue by Type (2019-2030)
7.2 North America T-Cell therapy Revenue by Application (2019-2030)
7.3 North America T-Cell therapy Revenue and Market Share by Countries
7.3.1 North America T-Cell therapy Revenue in Value by Country (2019-2030)
7.3.2 United States T-Cell therapy Revenue and Growth (2019-2030)
7.3.3 Canada T-Cell therapy Revenue and Growth (2019-2030)
7.3.4 Mexico T-Cell therapy Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe T-Cell therapy by Country, by Type, and by Application
8.1 Europe T-Cell therapy Revenue by Type (2019-2030)
8.2 Europe T-Cell therapy Revenue by Application (2019-2030)
8.3 Europe T-Cell therapy Revenue and Market Share by Countries
8.3.1 Europe T-Cell therapy Revenue in Value by Country (2019-2030)
8.3.2 Germany T-Cell therapy Revenue and Growth (2019-2030)
8.3.3 France T-Cell therapy Revenue and Growth (2019-2030)
8.3.4 United Kingdom T-Cell therapy Revenue and Growth (2019-2030)
8.3.5 Russia T-Cell therapy Revenue and Growth (2019-2030)
8.3.6 Italy T-Cell therapy Revenue and Growth (2019-2030)
8.3.7 Nordic T-Cell therapy Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific T-Cell therapy by Country, by Type, and by Application
9.1 Asia Pacific T-Cell therapy Revenue by Type (2019-2030)
9.2 Asia Pacific T-Cell therapy Revenue by Application (2019-2030)
9.3 Asia Pacific T-Cell therapy Revenue and Market Share by Countries
9.3.1 Asia Pacific T-Cell therapy Revenue in Value by Country (2019-2030)
9.3.2 China T-Cell therapy Revenue and Growth (2019-2030)
9.3.3 Japan T-Cell therapy Revenue and Growth (2019-2030)
9.3.4 Korea T-Cell therapy Revenue and Growth (2019-2030)
9.3.5 India T-Cell therapy Revenue and Growth (2019-2030)
9.3.6 Southeast Asia T-Cell therapy Revenue and Growth (2019-2030)
9.3.7 Australia T-Cell therapy Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America T-Cell therapy by Country, by Type, and by Application
10.1 South America T-Cell therapy Revenue by Type (2019-2030)
10.2 South America T-Cell therapy Revenue by Application (2019-2030)
10.3 South America T-Cell therapy Revenue and Market Share by Countries
10.3.1 South America T-Cell therapy Revenue in Value by Country (2019-2030)
10.3.2 Brazil T-Cell therapy Revenue and Growth (2019-2030)
10.3.3 Argentina T-Cell therapy Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa T-Cell therapy by Country, by Type, and by Application
11.1 Middle East & Africa T-Cell therapy Revenue by Type (2019-2030)
11.2 Middle East & Africa T-Cell therapy Revenue by Application (2019-2030)
11.3 Middle East & Africa T-Cell therapy Revenue and Market Share by Countries
11.3.1 Middle East & Africa T-Cell therapy Revenue in Value by Country (2019-2030)
11.3.2 Turkey T-Cell therapy Revenue and Growth (2019-2030)
11.3.3 Egypt T-Cell therapy Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia T-Cell therapy Revenue and Growth (2019-2030)
11.3.5 UAE T-Cell therapy Revenue and Growth (2019-2030)
11.3.6 South Africa T-Cell therapy Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 T-Cell therapy Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 T-Cell therapy Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer

List of Tables and Figures

Figure T-Cell therapy Picture
Table Product Specifications of T-Cell therapy
Figure Global Revenue Market Share of T-Cell therapy by Types in 2023
Table Types of T-Cell therapy
Figure T-Cell therapy Market Share by Applications in 2023
Table Application of T-Cell therapy
Figure Global T-Cell therapy Revenue (2019 VS 2023 VS 2030)
Figure Global T-Cell therapy Revenue in Value (2019-2030)
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Merck KGaA Details
Table SWOT Analysis
Table Merck KGaA T-Cell therapy Revenue and Gross Margin (2019-2024)
Figure Merck KGaA Revenue Market Share 2019-2024
Table Johnson & Johnson Details
Table SWOT Analysis
Table Johnson & Johnson T-Cell therapy Revenue and Gross Margin (2019-2024)
Figure Johnson & Johnson Revenue Market Share 2019-2024
Table AbbVie, Inc. Details
Table SWOT Analysis
Table AbbVie, Inc. T-Cell therapy Revenue and Gross Margin (2019-2024)
Figure AbbVie, Inc. Revenue Market Share 2019-2024
Table Gilead Sciences, Inc. Details
Table SWOT Analysis
Table Gilead Sciences, Inc. T-Cell therapy Revenue and Gross Margin (2019-2024)
Figure Gilead Sciences, Inc. Revenue Market Share 2019-2024
Table Amgen, Inc. Details
Table SWOT Analysis
Table Amgen, Inc. T-Cell therapy Revenue and Gross Margin (2019-2024)
Figure Amgen, Inc. Revenue Market Share 2019-2024
Table Novartis AG Details
Table SWOT Analysis
Table Novartis AG T-Cell therapy Revenue and Gross Margin (2019-2024)
Figure Novartis AG Revenue Market Share 2019-2024
Table Sorrento Therapeutics, Inc. Details
Table SWOT Analysis
Table Sorrento Therapeutics, Inc. T-Cell therapy Revenue and Gross Margin (2019-2024)
Figure Sorrento Therapeutics, Inc. Revenue Market Share 2019-2024
Table Bristol Myers Squibb Company Details
Table SWOT Analysis
Table Bristol Myers Squibb Company T-Cell therapy Revenue and Gross Margin (2019-2024)
Figure Bristol Myers Squibb Company Revenue Market Share 2019-2024
Table Immunocore Holdings plc Details
Table SWOT Analysis
Table Immunocore Holdings plc T-Cell therapy Revenue and Gross Margin (2019-2024)
Figure Immunocore Holdings plc Revenue Market Share 2019-2024
Table Pfizer, Inc. Details
Table SWOT Analysis
Table Pfizer, Inc. T-Cell therapy Revenue and Gross Margin (2019-2024)
Figure Pfizer, Inc. Revenue Market Share 2019-2024
Table Global T-Cell therapy Revenue by Manufacturer (2019-2024)
Figure Global T-Cell therapy Revenue Market Share by Manufacturer in 2023
Figure Global Top 3 Companies Revenue Share in 2023
Figure Global Top 6 Companies Revenue Share in 2023
Table Global T-Cell therapy Manufacturers Market Concentration Ratio (CR5) (2019-2024)
Table T-Cell therapy Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Global T-Cell therapy Revenue in Value by Type (2019-2030)
Table Global T-Cell therapy Revenue Share by Type (2019-2030)
Table Global T-Cell therapy Revenue by Application (2019-2030)
Table Global T-Cell therapy Revenue Share by Application (2019-2030)
Figure Global T-Cell therapy Revenue and Growth (2019-2030)
Table Global T-Cell therapy Revenue by Regions (2019-2030)
Table Global T-Cell therapy Revenue Market Share by Regions (2019-2030)
Figure North America T-Cell therapy Revenue and Growth (2019-2030)
Figure Europe T-Cell therapy Revenue and Growth (2019-2030)
Figure Asia Pacific T-Cell therapy Revenue and Growth (2019-2030)
Figure South America T-Cell therapy Revenue and Growth (2019-2030)
Figure Middle East and Africa T-Cell therapy Revenue and Growth (2019-2030)
Table North America T-Cell therapy Revenue by Type (2019-2030)
Table North America T-Cell therapy Revenue by Application (2019-2030)
Table North America T-Cell therapy Revenue by Countries (2019-2030)
Table North America T-Cell therapy Revenue Market Share by Countries (2019-2030)
Figure United States T-Cell therapy Revenue and Growth (2019-2030)
Figure Canada T-Cell therapy Revenue and Growth (2019-2030)
Figure Mexico T-Cell therapy Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Europe T-Cell therapy Revenue by Type (2019-2030)
Table Europe T-Cell therapy Revenue by Application (2019-2030)
Table Europe T-Cell therapy Revenue by Countries (2019-2030)
Table Europe T-Cell therapy Revenue Market Share by Countries (2019-2030)
Figure Germany T-Cell therapy Revenue and Growth (2019-2030)
Figure France T-Cell therapy Revenue and Growth (2019-2030)
Figure United Kingdom T-Cell therapy Revenue and Growth (2019-2030)
Figure Russia T-Cell therapy Revenue and Growth (2019-2030)
Figure Italy T-Cell therapy Revenue and Growth (2019-2030)
Figure Nordic T-Cell therapy Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Asia Pacific T-Cell therapy Revenue by Type (2019-2030)
Table Asia Pacific T-Cell therapy Revenue by Application (2019-2030)
Table Asia Pacific T-Cell therapy Revenue by Countries (2019-2030)
Table Asia Pacific T-Cell therapy Revenue Market Share by Countries (2019-2030)
Figure China T-Cell therapy Revenue and Growth (2019-2030)
Figure Japan T-Cell therapy Revenue and Growth (2019-2030)
Figure Korea T-Cell therapy Revenue and Growth (2019-2030)
Figure India T-Cell therapy Revenue and Growth (2019-2030)
Figure Southeast Asia T-Cell therapy Revenue and Growth (2019-2030)
Figure Australia T-Cell therapy Revenue and Growth (2019-2030)
Table SWOT Analysis
Table South America T-Cell therapy Revenue by Type (2019-2030)
Table South America T-Cell therapy Revenue by Application (2019-2030)
Table South America T-Cell therapy Revenue by Countries (2019-2030)
Table South America T-Cell therapy Revenue Market Share by Countries (2019-2030)
Figure Brazil T-Cell therapy Revenue and Growth (2019-2030)
Figure Argentina T-Cell therapy Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Middle East & Africa T-Cell therapy Revenue by Type (2019-2030)
Table Middle East & Africa T-Cell therapy Revenue by Application (2019-2030)
Table Middle East & Africa T-Cell therapy Revenue by Countries (2019-2030)
Table Middle East & Africa T-Cell therapy Revenue Market Share by Countries (2019-2030)
Figure Turkey T-Cell therapy Revenue and Growth (2019-2030)
Figure Egypt T-Cell therapy Revenue and Growth (2019-2030)
Figure Saudi Arabia T-Cell therapy Revenue and Growth (2019-2030)
Figure UAE T-Cell therapy Revenue and Growth (2019-2030)
Figure South Africa T-Cell therapy Revenue and Growth (2019-2030)
Table SWOT Analysis
Figure Proportion of Business Cost Structure
Table Labor Cost Analysis
Table Operating Expenses Analysis
Figure T-Cell therapy Industrial Chain Analysis
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report